Global headquarters was established in Basel
Country of origin
The Roivant Group focuses on the development of innovative drugs in neurology, oncology, endocrinology, dermatology and hepatology.
In 2016, the global headquarters was established in Basel. At the same time, partner companies moved to Basel, including Axovant Sciences, which focuses on the treatment of dementia. It is also gratifying to note that Roivant Sciences has joined the BaseLaunch circle of partners. Basel Area Business & Innovation assisted Roivant Sciences and its affiliated companies in evaluating and relocating to the site.
”We support BaseLaunch in the process of selecting new projects and we offer advice and mentorship. For us, it is a great way to signal our support for the local startup scene and develop our relationships with other companies in Basel. We are happy to be a part of that.Vivek RamaswamyFounder and CEO of Roivant Sciences
Basel is emblematic in that sense because it brings together a very diverse talent pool from multiple countries and cultures, speaking different languages with varied experiences and educational backgrounds.
Vivek Ramaswamy founded the company with the mission of systematically reducing the time, cost and risk of bringing new drugs to market and sharing these savings with the healthcare system. In less than five years it has become one of the most prominent biotech companies in the world.